Abstract
We studied 32 HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria (NTM). Immunologic studies included lymphocyte subset analysis by flow cytometry, measurement of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) production followingin vitro stimulation of diluted whole blood (DWB) and peripheral blood mononuclear cells (PBMC) by phytohemagglutinin (PHA), anti-CD3 as well as purified protein derivative of tuberculin (PPD), and in four cases with different amounts of the very mycobacterium, which caused disease in these patients. Data were compared to those of 30 HIV-seronegative patients with disease byMycobacterium tuberculosis (MTb). Following α-CD3-stimulation of PBMC, NTM patients showed lower IFN-γ(P < 0.00005) and lower TNF-α(P < 0.02). For a subgroup of tuberculin skin test-positive NTM patients we found significantly lower PPD-induced IFN-γ releases in cultured DWB(P < 0.0002) and PBMC(P < 0.0004) compared to MTb patients. Data for PPD-induced TNF-α release for this subgroup were also significant(P < 0.001 andP < 0.05, respectively). The four NTM patients with poor PPD-induced IFN-γ response hardly showed increased cytokine production on stimulation with their specific mycobacterium. The lower production capacity of IFN-γ and TNF-α of NTM patients compared to the MTb patients points to an immunologic imbalance forming the basis for their increased susceptibility to pulmonary infections by nontuberculous mycobacteria.
Similar content being viewed by others
REFERENCES
Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107-159, 1979
Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE: Infection with Mycobacterium avium complex in patients without predisposing conditions [see comments]. N Engl J Med 321:863-868, 1989
Reich JM, Johnson RE: Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis 143:1381-1385, 1991
Rosenzweig DY: Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases. Chest 75:115-119, 1979
Etzkorn ET, Aldarondo S, McAllister KC, Matthels J, Ognebene AJ: Medical therapy of Mycobacterium avium-intracellulare pulmonary disease. Am Rev Respir Dis 134:442-445, 1986
Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158:670-689, 1983
Schluger NW, Rom WN: The host immune response to tuberculosis. Am J Respir Crit Care Med 157:679-691, 1998
Onwubalili JK, Scott GM, Robinson JA: Deficient immune interferon production in tuberculosis. Clin Exp Immunol 59:405-413, 1985
Taha RA, Kotsimbos TC, Song YL, Menzies D, Hamid Q: IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. Am J Respir Crit Care Med 155:1135-1139, 1997
Sodhi A, Gong J, Silva C, Qian D, Barnes PF: Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis 25:617-620, 1997
Levin M, Newport MJ, D'Souza S, Kalabalikis P, Brown IN, Lenicker HM, Agius PV, Davies EG, Thrasher A, Klein N, Blackwell JM: Familial disseminated atypical mycobacterial infection in childhood: A human mycobacterial susceptibility gene? [see comments]. Lancet 345:79-83, 1995
Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, Casanova JL: Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335:1956-1961, 1996
Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M: A mutation in the interferon-gammareceptor gene and susceptibility to mycobacterial infection. N Engl J Med 335:1941-1949, 1996
Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, Gallin JI: Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 330:1348-1355, 1994
Chatte G, Panteix G, Perrin-Fayolle M, Pacheo Y: Aerolized interferon gamma for Mycobacterium avium-complex lung disease. Am J Respir Crit Care Med 152:1094-1096, 1995
Kindler V, Sappino AP, Grau GE, Piguet PF, Vassali P: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740, 1989
Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S: IL4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by TH1 and TH2 cell clones. J Immunol 149:2977-2983, 1992
American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156:S1-25, 1997
Hartman T, Swensen SJ, Williams DE: Mycobacterium avium-intracellulare complex: Evaluation with CT. Radiology 187:23-26, 1993
Kimura M, Converse PJ, Atemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NMH, Chaisson R, Bishai WR: Comparison between a whole blood interferon gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. J Infect Dis 179:1297-1300, 1999
von Reyn CF, Williams DE, Horsburgh Jr. CR, Jaeger AS, Marsh BJ, Haslov K, Magnusson M: Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 177:730-736, 1998
Kabelitz D: Do CD2 and CD3-TCR T-cell activation pathways function independently? Immunol Today 11(2):44-47, 1990
Abb J, Abb H, Deinhardt F: Age-related decline of human interferon alpha and interferon gamma production. Blut 48:285-289, 1984
Vilcek J, Klion A, Henriksen-DeStefano D, Zemtsov A, Davidson DM, Davidson M, Friedman-Kien AE, Le J: Defective gammainterferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 6:146-151, 1986
Mason III UG, Greenberg LE, Yen SS, Kirkpatrick CH: Indomethacin-responsive mononuclear cell dysfunction in “atypical” mycobacteriosis. Cell Immunol 71:54-65, 1982
Froebel KS, Bollert FG, Jellema J, Bird AG, Greening AP: Immunodeficiency in nontuberculous mycobacterial disease. Respir Med 91:95-101, 1997
Huang J, Oefner PJ, Adi V, Ratnam K, Ruoss SJ, Trako E, and Kao PN: Analysis of the NRAMP1 and IFN-gamma R1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med 157(2):377-381, 1998
Condos R, Rom W, Schluger N: Treatment of multi-drug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 349:1513-1515, 1997
Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing CD4 T cells. J Exp Med 178:1655-1663, 1993
Giosuè S, Casarini M, Alemanno L, Gallucio G, Mattai P, Pedicelli G, Rebek L, Bisetti A, Ameglio F: Effects of aerolized interferonalpha in patients with pulmonary tuberculosis. Am J Resp Crit Care Med 158:1156-1162, 1998
Bermudez LE, Young LS: Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140:3006-3013, 1988
Ottenhoff TMH, Kumararatne D, Casanova J-L: Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunology Today 10:491-494, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Greinert, U., Schlaak, M., Rũsch-Gerdes, S. et al. Low In Vitro Production of Interferon-γ and Tumor Necrosis Factor-α in HIV-Seronegative Patients with Pulmonary Disease Caused by Nontuberculous Mycobacteria. J Clin Immunol 20, 445–452 (2000). https://doi.org/10.1023/A:1026407815946
Issue Date:
DOI: https://doi.org/10.1023/A:1026407815946